Bolt Medical Announces Results of First 60 Patients in RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular Lithotripsy System by Seini Moimoi | May 29, 2024 | Portfolio News
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN) by Seini Moimoi | May 28, 2024 | Portfolio News
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis by Seini Moimoi | May 19, 2024 | Portfolio News
89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Compensated Cirrhosis by Seini Moimoi | May 14, 2024 | Portfolio News
Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs by Seini Moimoi | May 7, 2024 | Portfolio News
